Peer review reports
From: Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
Original Submission | ||
---|---|---|
19 Feb 2022 | Submitted | Original manuscript |
22 Mar 2022 | Reviewed | Reviewer Report |
24 Mar 2022 | Reviewed | Reviewer Report - Jianwei Xuan |
30 Mar 2022 | Author responded | Author comments - Jefferson Antonio Buendía |
12 Apr 2022 | Reviewed | Reviewer Report |
7 May 2022 | Reviewed | Reviewer Report |
18 May 2022 | Author responded | Author comments - Jefferson Antonio Buendía |
Resubmission - Version 2 | ||
30 Mar 2022 | Submitted | Manuscript version 2 |
20 May 2022 | Author responded | Author comments - Jefferson Antonio Buendía |
Resubmission - Version 3 | ||
20 May 2022 | Submitted | Manuscript version 3 |
25 May 2022 | Author responded | Author comments - Jefferson Antonio Buendía |
Resubmission - Version 4 | ||
25 May 2022 | Submitted | Manuscript version 4 |
Publishing | ||
27 May 2022 | Editorially accepted | |
23 Jun 2022 | Article published | 10.1186/s12890-022-02029-4 |